Beta-adrenergic receptor blocking drugs.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy; D001014:Aortic Aneurysm / Q000188:drug therapy; D001021:Aortic Valve; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D003326:Coronary Circulation / Q000187:drug effects; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008881:Migraine Disorders / Q000188:drug therapy; D009440:Neurasthenia / Q000188:drug therapy; D005996:Nitroglycerin / Q000627:therapeutic use; D010096:Oxprenolol / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000175:diagnosis; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use; D011941:Receptors, Adrenergic; D013015:Sotalol / Q000627:therapeutic use; D013771:Tetralogy of Fallot / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D011941:Receptors, Adrenergic; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D013015:Sotalol; D005996:Nitroglycerin